MH

Mohd Hasan

Active Director Director DIN 10141544
DIN 10141544 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohd Hasan

Data last updated:

Mohd Hasan is a Director at Pdi Pharmaceuticals Private Limited (since 2023) and Director at Boldpact Edutech Association (since 2023). The companies operate in Paper and Education.

DIN 10141544
Primary Designation Director
Industry Paper
First Appointment 29 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pdi Pharmaceuticals Private Limited U21002UP2023PTC184699
Director28 Jun 20232023Active
Boldpact Edutech Association U88900UP2023NPL181182
Director29 Apr 20232023Active

Board colleagues of Mohd Hasan

Directorship timeline

Open interactive timeline →
Boldpact Edutech Association
Pdi Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohd Hasan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Hasan

Mohd Hasan currently holds 2 directorships: Pdi Pharmaceuticals Private Limited (Director, since 28 Jun 2023); Boldpact Edutech Association (Director, since 29 Apr 2023).

Mohd Hasan was first appointed on 29 Apr 2023 as Director at Boldpact Edutech Association.

The current boards of Mohd Hasan's companies include Subhan Hasan Khan (Pdi Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available